Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Medical Innovation Acceleration Act of 2025 This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
Introduced
Jan 3, 2025
Last Action
Jan 3, 2025
Session
119th Congress
Sponsors
1 primary · 0 co
Passage Probability
2% — Very Low
Introduced in House
Referred to the House Committee on Energy and Commerce.
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
2%
Estimate based on legislative signals
See what factors are driving this score — cosponsor support, bipartisan backing, committee progress, and more.
Upgrade to ProReferred to the House Committee on Energy and Commerce.